Denmark medical cannabis sales mostly on the rise, but pilot program sputters

Denmark’s medical cannabis sales took a breather in 2022 after experiencing consistent growth for half a decade, according to new data from the Danish Health and Medicines Authority.

Argentina launches cannabis regulatory agency with eye on exports

Argentina launched a national regulatory agency for the hemp and medical marijuana industries, aiming to capitalize on the domestic and international markets.

Danish marijuana companies attracted $217 million in funding, report finds

Medical marijuana companies in Denmark attracted external capital of more than 1.5 billion Danish kroner ($217 million), including founders’ own investments, which works out to an average of $6 million per business.

Denmark medical cannabis sales post a positive quarter thanks to Epidiolex

Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ cannabis drug Epidiolex.

Insurance-covered medical cannabis reimbursements decline again in Germany

Public health insurance reimbursements for cannabis in Germany have fallen for the second straight quarter.

First prescriptions of high-THC products imminent in Peru

Khiron Life Sciences – a Toronto-based company with its main operations in Colombia – announced Thursday that it completed the first export from Colombia of high-THC medical cannabis products.

Argentina redraws medical cannabis rules, allowing home cultivation

Argentinian authorities published a new decree aiming to address the shortcomings of the rules governing the country’s medical cannabis sector, which has largely failed to materialize since an initial law and decree were approved in 2017.

More medical cannabis products available in Peruvian pharmacies

The first finished, registered cannabis medicine became available to patients in Peruvian pharmacies this week, Marijuana Business Daily has learned.

Danish medical cannabis market sees positive quarter

Denmark’s medical cannabis pilot program notched another positive quarter, but the number of unique consumers remains well below the trial’s peak of a year ago.

New CBD product available under prescription in Peru

A new medical cannabis product is available in Peru, another sign the market is moving in the right direction in terms of business opportunities.

Insurance-covered medical cannabis falls for the first time in Germany

Insurance reimbursements for cannabis in Germany dropped for the first time – on a quarterly basis – since the current medical program started in early 2017, according to new data for the quarter ended June 30, 2020.